Ignite Creation Date:
2024-07-17 @ 11:23 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06499233
Status:
RECRUITING
Last Update Posted:
2024-07-15
First Post:
2024-07-06
Brief Title:
Efficacy and Safety of Prophylactic Treatment for Pneumocystis Jirovecii Pneumonia in Patients With Autoimmune Inflammatory Rheumatic Disease
Sponsor:
Tongji Hospital
Organization:
Tongji Hospital
Study Overview
Official Title:
Efficacy and Safety of Prophylactic Treatment for Pneumocystis Jirovecii Pneumonia PJP in Patients With Autoimmune Inflammatory Rheumatic Disease AIIRD
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is an open-labeled prospective clinical study aims at collecting and analyzing baseline characteristics of autoimmune inflammatory rheumatic disease AIIRD patients receiving sulfanilamide for preventive purposes as well as subsequent follow-up data in order to assess the efficacy and safety of the medication Additionally through a stratified analysis of risk factors the investigators aim to identify the AIIRD population that would benefit most from preventive medication based on a favorable benefit-risk ratio
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
None